RAICHUR, Indien, 13. März 2025 /PRNewswire/ -- Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), ein führender Hersteller von Wirkstoffen und Formulierungen, gibt bekannt, dass der Sachverständigenausschuss (SEC) der CDSCO sein neues Prüfpräparat (Investigational New Drug, IND) –...
Hence then, the article about shilpa medicare sichert sich sec cdsco nod fur nor ursodeoxycholsaure tabletten und strebt markteinfuhrung fur nash an was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Shilpa Medicare sichert sich SEC-CDSCO Nod für Nor-Ursodeoxycholsäure-Tabletten und strebt Markteinführung für NASH an )
Also on site :
- Denver Fire Department responds to 3-alarm fire at intersection of Leetsdale Drive and S. Forest Street
- China’s special envoy meets Maduro (VIDEO)
- Trial to begin for police officer charged in delayed response to Uvalde school shooting